Bolt Biotherapeutics BOLT
NASDAQ BOLT
$6.63 +2.44 (+58.51%)
As of: Oct 23, 2026 · 2:45 PM EDT

Bolt Biotherapeutics (BOLT) Cash & Current Investments (2020 - 2026)

Updated

Bolt Biotherapeutics' Cash & Current Investments came in at $18.1 million for Q2 2026, down 62.7% from $48.5 million a year earlier and down 24.3% from the prior quarter.

Analysis

Bolt Biotherapeutics (BOLT) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Bolt Biotherapeutics' Cash & Current Investments was $31.8 million, down 54.7% from FY2024.

  • Cash & Current Investments has declined in each of the last three years, though with a five-year compound annual growth rate of 6.8% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $70.2 million in FY2024 (-45.4%), $128.6 million in FY2023 (-33.3%), $192.8 million in FY2022 (+3.5%) and $186.22 million in FY2021 (+715.4%).
  • The Q2 2026 figure represents the lowest quarterly Cash & Current Investments since Q3 2020.
  • Year-over-year, Cash & Current Investments has declined for 14 consecutive quarters, with an average decline of 51.8% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q4 2021 (growth of 715.4%), and the weakest in Q2 2026 (a decline of 62.7%).
  • Business Quant data shows BOLT's Cash & Current Investments at $23.9 million (Q1 2026), $31.8 million (Q4 2025) and $38.8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,124.12 Bn 1,092.71 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 634.38 Bn 554.24 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.39 Bn 478.50 Bn 12.70 Bn 6.57 Bn
4 Merck 357.36 Bn 311.74 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 290.21 Bn 254.20 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.21 Bn 238.89 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.81 Bn 193.21 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Bolt Biotherapeutics 12.79 Mn -5.31 Mn - 18.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.10 Mn
Mar 31, 2026 23.90 Mn
Dec 31, 2025 31.80 Mn
Sep 30, 2025 38.80 Mn
Jun 30, 2025 48.50 Mn
Mar 31, 2025 58.00 Mn
Dec 31, 2024 70.20 Mn
Sep 30, 2024 84.40 Mn
Jun 30, 2024 97.50 Mn
Mar 31, 2024 112.80 Mn
Dec 31, 2023 128.60 Mn
Sep 30, 2023 141.40 Mn
Jun 30, 2023 157.10 Mn
Mar 31, 2023 171.00 Mn
Dec 31, 2022 192.80 Mn
Sep 30, 2022 209.60 Mn
Jun 30, 2022 176.34 Mn
Mar 31, 2022 190.90 Mn
Dec 31, 2021 186.22 Mn
Sep 30, 2021 212.89 Mn
API Access

Bolt Biotherapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BOLT&period=max&api_key=YOUR_API_KEY